By vgreene, 23 December, 2014 Exclude Patient Type Detail Header No Detail Type Text Detail Text Offer oral antimuscarinics<sup>5,8</sup> or β3-adrenoceptor agonists (mirabegron) [S/B]. Transdermal oxybutynin patch/gel OTC<sup>8</sup> may be offered. [R/C] If inadequate sx control<sup>2</sup> and/or unacceptable ADE w/ 1 antimuscarinic:<sup>5,6</sup> manage constipation/dry mouth,<sup>4</sup> modify dose, or try a different antimuscarinic or a β3-adrenoceptor agonist (mirabegron). [CP] If refractory to behavioral and drug tx:<sup>2</sup> eval by specialist if additional tx desired [EO]. Consider UCx, PVR, bladder diary/sx questionnaire, etc.